Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
8.68
+0.17 (2.00%)
Mar 11, 2026, 11:51 AM EDT - Market open
Passage Bio Market Cap
Passage Bio has a market cap or net worth of $27.84 million as of March 11, 2026. Its market cap has decreased by -12.96% in one year.
Market Cap
27.84M
Enterprise Value
5.01M
1-Year Change
-12.96%
Ranking
Category
Stock Price
$8.68
Market Cap Chart
Since February 28, 2020, Passage Bio's market cap has decreased from $956.75M to $27.84M, a decrease of -97.09%. That is a compound annual growth rate of -44.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 27.30M | -27.22% |
| Dec 31, 2025 | 37.51M | 7.08% |
| Dec 31, 2024 | 35.03M | -36.74% |
| Dec 29, 2023 | 55.37M | -26.45% |
| Dec 30, 2022 | 75.28M | -78.09% |
| Dec 31, 2021 | 343.58M | -70.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AEON Biopharma | 29.10M |
| NeuroSense Therapeutics | 29.00M |
| Kyntra Bio | 28.84M |
| Hyperion DeFi | 27.63M |
| IGC Pharma | 27.31M |
| BriaCell Therapeutics | 27.09M |
| FibroBiologics | 26.77M |
| Exicure | 26.26M |